Works matching DE "RIBAVIRIN"
Results: 3319
Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial.
- Published in:
- Diabetes Care, 2025, v. 48, n. 3, p. 481, doi. 10.2337/dc24-2121
- By:
- Publication type:
- Article
The Combination of GS-441524 (Remdesivir) and Ribavirin Results in a Potent Antiviral Effect Against Human Parainfluenza Virus 3 Infection in Human Airway Epithelial Cell Cultures and in a Mouse Infection Model.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 172, doi. 10.3390/v17020172
- By:
- Publication type:
- Article
A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs).
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 163, doi. 10.3390/v17020163
- By:
- Publication type:
- Article
The Nucleoside Analog GS-441524 Effectively Attenuates the In Vitro Replication of Multiple Lineages of Circulating Canine Distemper Viruses Isolated from Wild North American Carnivores.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 150, doi. 10.3390/v17020150
- By:
- Publication type:
- Article
Bovine Serum Albumin Nanoparticle-Mediated Delivery of Ribavirin and Mycophenolic Acid for Enhanced Antiviral Therapeutics.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 138, doi. 10.3390/v17020138
- By:
- Publication type:
- Article
Peginterferon alfa-2b and ribavirin therapy in Kuwaiti patients with chronic hepatitis C virus infection.
- Published in:
- Eastern Mediterranean Health Journal, 2011, v. 17, n. 8, p. 669, doi. 10.26719/2011.17.8.669
- By:
- Publication type:
- Article
Hepatitis C part 2: Treatment and prevention.
- Published in:
- Practice Nursing, 2012, v. 23, n. 11, p. 540, doi. 10.12968/pnur.2012.23.11.540
- By:
- Publication type:
- Article
Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine.
- Published in:
- Wiener Klinische Wochenschrift, 2004, v. 116, n. 15/16, p. 530
- By:
- Publication type:
- Article
Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon α -- hype or hope?
- Published in:
- Wiener Klinische Wochenschrift, 2004, v. 116, n. 15/16, p. 508, doi. 10.1007/BF03217702
- By:
- Publication type:
- Article
Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Effect of Aging, Glucose Level, and HIV Viral Load on Response to Treatment with Pegylated Interferon Plus Ribavirin in HIV/HCV Co-Infected Women.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Cut and Paste for Cancer Treatment: A DNA Nanodevice that Cuts Out an RNA Marker Sequence to Activate a Therapeutic Function.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 47, p. 21376, doi. 10.1002/ange.202006384
- By:
- Publication type:
- Article
Treatment of HCV in renal transplant patients with peginterferon and ribavirin: long-term follow-up.
- Published in:
- Clinical & Experimental Nephrology, 2017, v. 21, n. 5, p. 764, doi. 10.1007/s10157-016-1364-7
- By:
- Publication type:
- Article
In Vivo Inhibition of Trans-Plasma Membrane Electron Transport by Antiviral Drugs in Grapevine.
- Published in:
- Journal of Membrane Biology, 2013, v. 246, n. 7, p. 513, doi. 10.1007/s00232-013-9572-5
- By:
- Publication type:
- Article
Ribavirin, but not interferon alpha-2b, is associated with impaired osteoblast proliferation and differentiation in vitro.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Interferon alpha-2a Plus Ribavirin 1,000/1,200 mg versus Interferon alpha-2a Plus Ribavirin 600 mg for Chronic Hepatitis C Infection in Patients on Opiate Maintenance Treatment: An Open-Label Randomized Multicenter Trial.
- Published in:
- Infection, 2005, v. 33, n. 1, p. 25, doi. 10.1007/s15010-005-4043-2
- By:
- Publication type:
- Article
Sequential Changes of Hepatitis C Virus Antibody Profiles during Treatment of Chronic Hepatitis C of Genotype 1b: Pretreatment Antibody Response to E2/NS1 Correlated Sustained Response.
- Published in:
- Infection, 2004, v. 32, n. 3, p. 153, doi. 10.1007/s15010-004-3133-x
- By:
- Publication type:
- Article
The time-course of ribavirin-provoked changes of basal and AMPH-induced motor activities in rats.
- Published in:
- Experimental Brain Research, 2005, v. 165, n. 3, p. 402, doi. 10.1007/s00221-005-2311-0
- By:
- Publication type:
- Article
Artesunate, an anti-malarial drug, has a potential to inhibit HCV replication.
- Published in:
- Virus Genes, 2016, v. 52, n. 1, p. 22, doi. 10.1007/s11262-015-1285-7
- By:
- Publication type:
- Article
Emergence of genetically variant Hepatitis C virus population in response to increased antiviral drug pressure, Pakistan.
- Published in:
- Virus Genes, 2014, v. 48, n. 3, p. 543, doi. 10.1007/s11262-014-1047-y
- By:
- Publication type:
- Article
9-Sulfonyl-9(H)-Purine Derivatives Inhibit HCV Replication Via their Degradation Species.
- Published in:
- Pharmaceutical Chemistry Journal, 2021, v. 55, n. 1, p. 36, doi. 10.1007/s11094-021-02369-1
- By:
- Publication type:
- Article
Quantitative UV-Spectrophotometric Determination of Ribavirin.
- Published in:
- Pharmaceutical Chemistry Journal, 2019, v. 53, n. 2, p. 175, doi. 10.1007/s11094-019-01974-5
- By:
- Publication type:
- Article
A New Effective Method for the Synthesis of 1,2,4-Triazole-3-carboxamide and Ribavirin Derivatives.
- Published in:
- Pharmaceutical Chemistry Journal, 2005, v. 39, n. 4, p. 212, doi. 10.1007/s11094-005-0119-7
- By:
- Publication type:
- Article
A New Mixed-Ligand Ni(II) Complex: Crystal Structure, Protective and Anti-Inflammatory Activities of its Nanoparticles on Acute Viral Myocarditis by Reducing the Release of Inflammatory Cytokines TNF-α and IL-1β.
- Published in:
- Journal of Structural Chemistry, 2020, v. 61, n. 6, p. 948, doi. 10.1134/S0022476620060153
- By:
- Publication type:
- Article
Epidemiology and Natural History of Childhood-Acquired Chronic Hepatitis C: A Single-Center Long-Term Prospective Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Direct Acting Antiviral Treatment Selection in a Child With Hepatitis C Virus Infection and Compensated Cirrhosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment of Chronic Hepatitis C Virus Infection in Children: A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-Term Follow-Up of Children Treated With Peginterferon and Ribavirin for Hepatitis C Virus Infection.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Durability of Response in Children Treated With Pegylated Interferon alfa [corrected] 2a ± Ribavirin for Chronic Hepatitis C.
- Published in:
- 2016
- By:
- Publication type:
- journal article
IL28B rs12979860 gene polymorphism and sofosbuvir-based therapy response in HCV-infected Pakistani patients.
- Published in:
- International Journal of Medical Biochemistry, 2024, v. 7, n. 2, p. 73, doi. 10.14744/ijmb.2024.75437
- By:
- Publication type:
- Article
REPARO DE LESÃO PERIAPICAL PÓS-TRATAMENTO ENDODÔNTICO EM PACIENTE PORTADOR DE HEPATITE C: RELATO DE CASO.
- Published in:
- Revista Foco (Interdisciplinary Studies Journal), 2023, v. 16, n. 3, p. 1, doi. 10.54751/revistafoco.v16n3-122
- By:
- Publication type:
- Article
The efficacy and safety of ombitasvir/paritaprevir/ritonavir plus ribavirin in hepatitis C virus‑infected patients with end‑stage renal disease on regular hemodialysis.
- Published in:
- Journal of Medicine in Scientific Research, 2021, v. 4, n. 2, p. 170, doi. 10.4103/jmisr.jmisr_114_20
- By:
- Publication type:
- Article
Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00371-y
- By:
- Publication type:
- Article
The broad-spectrum antiviral recommendations for drug discovery against COVID-19.
- Published in:
- Drug Metabolism Reviews, 2020, v. 52, n. 3, p. 408, doi. 10.1080/03602532.2020.1770782
- By:
- Publication type:
- Article
Effectiveness, tolerability and safety of Direct Acting Antivirals in Mexican individuals with Hepatitis C virus genotype-1 and previous pegylated interferon and ribavirin therapy.
- Published in:
- PeerJ, 2021, p. 1, doi. 10.7717/peerj.12051
- By:
- Publication type:
- Article
Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial.
- Published in:
- PeerJ, 2021, p. 1, doi. 10.7717/peerj.10709
- By:
- Publication type:
- Article
Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C.
- Published in:
- PeerJ, 2019, p. 1, doi. 10.7717/peerj.7666
- By:
- Publication type:
- Article
Effect of Sofosbuvir plus Ribavirin therapy on hepatitis C patients in Pakistan: a retrospective study.
- Published in:
- PeerJ, 2019, p. 1, doi. 10.7717/peerj.4853
- By:
- Publication type:
- Article
Effect of Sofosbuvir plus Ribavirin therapy on hepatitis C patients in Pakistan: a retrospective study.
- Published in:
- PeerJ, 2018, v. 6, p. 1, doi. 10.7717/peerj.4853
- By:
- Publication type:
- Article
Micro-elimination of hepatitis C in patients with chronic kidney disease: an Egyptian single-center study.
- Published in:
- Egyptian Journal of Internal Medicine, 2022, v. 34, n. 1, p. 1, doi. 10.1186/s43162-022-00139-3
- By:
- Publication type:
- Article
Methotrexate, an anti-inflammatory drug, inhibits Hepatitis E viral replication.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2280500
- By:
- Publication type:
- Article
Statement of retraction: [thiophen urea derivatives as a new class of hepatitis C virus entry inhibitors].
- Published in:
- 2021
- Publication type:
- Correction Notice
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2017, v. 32, n. 1, p. 375, doi. 10.1080/14756366.2016.1256881
- By:
- Publication type:
- Article
Indirect Electrochemical Determination of Ribavirin Using Boronic Acid-Diol Recognition on a 3-Aminophenylboronic Acid-Electrochemically Reduced Graphene Oxide Modified Glassy Carbon Electrode (APBA/ERGO/GCE).
- Published in:
- Analytical Letters, 2019, v. 52, n. 12, p. 1900, doi. 10.1080/00032719.2019.1576716
- By:
- Publication type:
- Article
Determination of Ribavirin and Moisture in Pharmaceuticals by Near-Infrared Spectroscopy.
- Published in:
- Analytical Letters, 2016, v. 49, n. 13, p. 2077, doi. 10.1080/00032719.2015.1130715
- By:
- Publication type:
- Article
Insight into the efficacy of lipid nano-systems for brain delivery -- uptake and internalization pathways in different cell culture lines.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 219, doi. 10.33320/maced.pharm.bull.2022.68.03.104
- By:
- Publication type:
- Article
利巴韦林喷雾剂联合小儿豉翘清热颗粒对手足口病患儿外周血 T 淋巴细胞亚群、血清免疫球蛋白指标和炎性因子的影响.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 6, p. 1151, doi. 10.13241/j.cnki.pmb.2023.06.030
- By:
- Publication type:
- Article
FACTORS THAT INFLUENCE THE VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREAT ED WITH PEGYLAT ED INTERFERON AND RIBAVIRIN.
- Published in:
- Contributions / Prilozi (1857-9345), 2017, v. 38, n. 1, p. 25, doi. 10.1515/prilozi-2017-0003
- By:
- Publication type:
- Article
NEW THERAPIES FOR HEPATITIS C VIRUS.
- Published in:
- Contributions / Prilozi (1857-9345), 2015, v. 36, n. 2, p. 119, doi. 10.1515/prilozi-2015-0060
- By:
- Publication type:
- Article